| Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage MR Haymart, DJ Repplinger, GE Leverson, DF Elson, RS Sippel, ... The Journal of Clinical Endocrinology & Metabolism 93 (3), 809-814, 2008 | 673 | 2008 |
| Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? D Repplinger, A Bargren, YW Zhang, JT Adler, M Haymart, H Chen Journal of Surgical Research 150 (1), 49-52, 2008 | 376 | 2008 |
| Older age and larger tumor size predict malignancy in hürthle cell neoplasms of the thyroid YW Zhang, DY Greenblatt, D Repplinger, A Bargren, JT Adler, RS Sippel, ... Annals of Surgical Oncology 15, 2842-2846, 2008 | 66 | 2008 |
| Is tumor size the best predictor of outcome for papillary thyroid cancer? Y Cheema, D Repplinger, D Elson, H Chen Annals of surgical oncology 13, 1524-1528, 2006 | 60 | 2006 |
| Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism? AE Bargren, D Repplinger, H Chen, RS Sippel Journal of the American College of Surgeons 213 (3), 410-414, 2011 | 56 | 2011 |
| Higher serum TSH level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage MR Haymart, DJ Repplinger, GE Leverson, DF Elson, RS Sippel, ... J Clin Endocrinol Metab 93 (3), 809-814, 2008 | 38 | 2008 |
| Neurocognitive dysfunction: a predictor of parathyroid hyperplasia D Repplinger, S Schaefer, H Chen, RS Sippel Surgery 146 (6), 1138-1143, 2009 | 24 | 2009 |
| QS264. Factors that predict malignancy in Hürthle cell neoplasms of the thyroid YW Zhang, DY Greenblatt, D Repplinger, A Bargren, J Adler, H Chen Journal of Surgical Research 144 (2), 371-372, 2008 | 13 | 2008 |
| 118. Is Hashimoto’S Thyroiditis a Risk Factor for Papillary Thyroid Cancer? D Repplinger, A Bargren, YW Zhang, JT Adler, M Haymart, H Chen Journal of Surgical Research 144 (2), 228, 2008 | 4 | 2008 |
| WS05. 02 A Phase-1 multiple ascending dose healthy volunteer study to evaluate the safety, tolerability, and pharmacokinetics of GDC-6988, a dry powder formulation of a … P Miller, R Zhu, D Repplinger, Y Chen, G She, N Singh, J Galanter Journal of Cystic Fibrosis 22, S9, 2023 | | 2023 |
| 180 First-in-human study to evaluate safety, tolerability, and pharmacokinetics of GDC-6988 (ETD002), a selective inhaled potentiator of the TMEM16A chloride channel P Russell, N Lewin-Koh, R Zhu, K Woodward, D Morris, D Wilkes, ... Journal of Cystic Fibrosis 21, S105, 2022 | | 2022 |
| Possono le alterazioni biochimiche predire la sintomatologia in pazienti affetti da iperparatiroidismo primario? AE Bargren, D Repplinger, H Chen, RS Sippel, M Prete, A Colao, ... L'Endocrinologo 5 (12), 260-261, 2011 | | 2011 |
| Central neck dissection in node negative papillary thyroid cancer: Is it overkill or the optimal operation? D Abraham, D Repplinger, Y Zhang, H Chen, RS Sippel ANNALS OF SURGICAL ONCOLOGY 15, 47-47, 2008 | | 2008 |
